Orexo AB (publ) (STO: ORX) Stock Analysis & Fundamentals

ORXOrexo AB (publ)

STO · SE · Healthcare · Drug Manufacturers - Specialty & Generic · orexo.com

14.04SEK+0.14%Mkt Cap: 47.11M $P/E: —Today

Orexo AB (publ), a pharmaceutical company, provides advance treatments for severe diseases and life-saving rescue medications in the United States, European Union, the United Kingdom, and internationally. Its products in…

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$65.24BUSDP/E 23.7

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

United Therapeutics Corporation

Swedish Orphan Biovitrum AB

$15.39BUSDP/E 118.0

NBIX

Neurocrine Biosciences, Inc.

Elanco Animal Health Incorporat

Hims & Hers Health, Inc.

Lantheus Holdings Inc

$6.56BUSDP/E 24.0

AMRX

Amneal Pharmaceuticals, Inc.

$6.23BUSDP/E 37.3

INDV

Indivior PLC Ordinary Shares

$4.61BUSDP/E 14.0

HIK

Hikma Pharmaceuticals PLC

$4.32BUSDP/E 12.5

AMLX

Amylyx Pharmaceuticals Inc. Common Stock

Laboratorios Farmaceuticos Rovi, S.A.

$3.34BUSDP/E 16.6

SUPN

Supernus Pharmaceuticals, Inc.

$2.82BUSD

Key Statistics

Company

Market Cap47.11M $

Enterprise Value21.57M $

Revenue (TTM)1.59M $

Gross Profit1.10M $

Net Income (TTM)61.15M $

Revenue/Share0.0456 USD

Last Price14.04 SEK

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees61

CountrySE

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-3.26

PEG13.07

EV/EBITDA-0.71

EV/Revenue13.58

P/S—

P/B1.81

EPS (TTM)-12.16

EPS (Forward)—

52W Range

13.701% of range43.40

52W High43.40 SEK

52W Low13.70 SEK

Profitability

Gross Margin44.23%

Oper. Margin-2945.71%

EBITDA Margin0.00%

Profit Margin2458.85%

ROE130.31%

ROA49.07%

Growth

Revenue Growth-27.10%

Earnings Growth—

Cash Flow & Leverage

Operating CF-18.69M $

CapEx (TTM)—

FCF Margin-366.42%

FCF Yield-12.35%

Net Debt-25.54M $

Net Debt/EBITDA0.84

Balance Sheet

Debt/Equity1.00

Current Ratio1.65

Quick Ratio1.59

Book Value/Sh7.724 SEK

Cash/Share7.883 SEK

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 SEK

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)26.50 SEK

Upside (mean)+88.7%

Target Range26.50 SEK – 26.50 SEK

# Analysts2

Ownership

Shares Out.35.13M

Float21.45M

Insiders10.13%

Institutions48.14%

Technical

SMA 5018.92 (-25.8%)

SMA 20023.35 (-39.9%)

Beta0.85

S&P 52W Chg18.16%

Avg Vol (30d)45.20K

Avg Vol (10d)27.88K

Technical Indicators

RSI (14)34.3

MACD-1.0804

MACD Signal-1.2905

MACD Hist.+0.2101

BB Upper15.69 SEK

BB Middle14.81 SEK

BB Lower13.93 SEK

BB Width11.88%

ATR (14)1.061 SEK

Vol Ratio (20d)0.82x